Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis

Eng Hooi Tan, Anthony G. Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L. Duvall, Kristine E. Lynch, Michael E. Matheny, View ORCID ProfileTalita Duarte-Salles, Sergio Fernandez Bertolin, George Hripcsak, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M Alshammari, Heba Alghoul, Osaid Alser, Jennifer C.E. Lane, Dalia M Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Relcade, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana YH Lai, Fredrik Nyberg, Daniel R Morales, Jose D. Posada, Nigam H. Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan P Minty, Marc Suchard, Peter Rijnbeek, Patrick B Ryan, View ORCID ProfileDaniel Prieto-Alhambra
doi: https://doi.org/10.1101/2020.11.24.20236802
Eng Hooi Tan
1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony G. Sena
2Janssen Research and Development, Titusville, NJ USA
3Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Prats-Uribe
1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seng Chan You
4Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Waheed-Ul-Rahman Ahmed
5Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
6College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kostka
7Real World Solutions, IQVIA, Cambridge, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Reich
7Real World Solutions, IQVIA, Cambridge, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott L. Duvall
8VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA
9Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristine E. Lynch
8VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA
9Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Matheny
10Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA
11Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talita Duarte-Salles
12Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Talita Duarte-Salles
Sergio Fernandez Bertolin
12Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hripcsak
13Department of Biomedical Informatics, Columbia University, New York, NY, US
14New York-Presbyterian Hospital, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Natarajan
13Department of Biomedical Informatics, Columbia University, New York, NY, US
14New York-Presbyterian Hospital, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Falconer
13Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Spotnitz
13Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Ostropolets
13Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clair Blacketer
2Janssen Research and Development, Titusville, NJ USA
3Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thamir M Alshammari
15Medication Safety Research Chair, King Saud Univeristy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Alghoul
16Faculty of Medicine, Islamic University of Gaza, Palestine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osaid Alser
17Massachusetts General Hospital, Harvard Medical School, Boston, 02114, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C.E. Lane
1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dalia M Dawoud
18Cairo University, Faculty of Pharmacy, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karishma Shah
5Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Yang
19DHC Technologies Co., LTD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
20School of Population Medicine and Public Health, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China
21Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3015, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Areia
22Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asieh Golozar
23Regeneron Pharmaceuticals, NY US
24Departament of Epidemiology, Johns Hopkins School of Public, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Relcade
12Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
25Universitat Autonoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Casajust
26Real-World Evidence, Trial Form Support, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jitendra Jonnagaddala
27School of Public Health and Community Medicine, UNSW Sydney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vignesh Subbian
28College of Engineering, The University of Arizona Tucson, Arizona, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Vizcaya
29Bayer Pharmaceuticals, Sant Joan Despi, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lana YH Lai
30School of Medical Sciences, University of Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Nyberg
31School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R Morales
32Division of Population Health Sciences, University of Dundee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose D. Posada
33Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigam H. Shah
33Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengchun Gong
34Health Management Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arani Vivekanantham
5Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Abend
35Autoimmune Registry Inc., 125 West Lane, Guilford, CT 06437
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan P Minty
36O’Brien School for Public Health, Faculty of Medicine, University of Calgary, 2500 University Drive NW, Calgary, Alberta T2N 1N4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Suchard
37Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rijnbeek
3Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick B Ryan
2Janssen Research and Development, Titusville, NJ USA
13Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Prieto-Alhambra
1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Prieto-Alhambra
  • For correspondence: daniel.prietoalhambra{at}ndorms.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.

Design Multinational network cohort study

Setting Electronic health records data from Columbia University Irving Medical Center (CUIMC) (NYC, United States [US]), Optum [US], Department of Veterans Affairs (VA) (US), Information System for Research in Primary Care-Hospitalisation Linked Data (SIDIAP-H) (Spain), and claims data from IQVIA Open Claims (US) and Health Insurance and Review Assessment (HIRA) (South Korea).

Participants All patients with prevalent autoimmune diseases, diagnosed and/or hospitalised between January and June 2020 with COVID-19, and similar patients hospitalised with influenza in 2017-2018 were included.

Main outcome measures 30-day complications during hospitalisation and death

Results We studied 133,589 patients diagnosed and 48,418 hospitalised with COVID-19 with prevalent autoimmune diseases. The majority of participants were female (60.5% to 65.9%) and aged ≥50 years. The most prevalent autoimmune conditions were psoriasis (3.5 to 32.5%), rheumatoid arthritis (3.9 to 18.9%), and vasculitis (3.3 to 17.6%). Amongst hospitalised patients, Type 1 diabetes was the most common autoimmune condition (4.8% to 7.5%) in US databases, rheumatoid arthritis in HIRA (18.9%), and psoriasis in SIDIAP-H (26.4%).

Compared to 70,660 hospitalised with influenza, those admitted with COVID-19 had more respiratory complications including pneumonia and acute respiratory distress syndrome, and higher 30-day mortality (2.2% to 4.3% versus 6.3% to 24.6%).

Conclusions Patients with autoimmune diseases had high rates of respiratory complications and 30-day mortality following a hospitalization with COVID-19. Compared to influenza, COVID-19 is a more severe disease, leading to more complications and higher mortality. Future studies should investigate predictors of poor outcomes in COVID-19 patients with autoimmune diseases.

What is already known about this topic

  • Patients with autoimmune conditions may be at increased risk of COVID-19 infection andcomplications.

  • There is a paucity of evidence characterising the outcomes of hospitalised COVID-19 patients with prevalent autoimmune conditions.

What this study adds

  • Most people with autoimmune diseases who required hospitalisation for COVID-19 were women, aged 50 years or older, and had substantial previous comorbidities.

  • Patients who were hospitalised with COVID-19 and had prevalent autoimmune diseases had higher prevalence of hypertension, chronic kidney disease, heart disease, and Type 2 diabetes as compared to those with prevalent autoimmune diseases who were diagnosed with COVID-19.

  • A variable proportion of 6% to 25% across data sources died within one month of hospitalisation with COVID-19 and prevalent autoimmune diseases.

  • For people with autoimmune diseases, COVID-19 hospitalisation was associated with worse outcomes and 30-day mortality compared to admission with influenza in the 2017-2018 season.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: DPA reports grants and other from AMGEN; grants, non-financial support and other from UCB Biopharma; grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programs organised by DPA's department and open for external participants. AG reports personal fees from Regeneron Pharmaceuticals, outside the submitted work; and she is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. CR and KK report being employees of IQVIA Inc. No other relationships or activities that could appear to have influenced the submitted work

Funding Statement

The European Health Data & Evidence Network (EHDEN) has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union s Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations (EFPIA). This research received partial support from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), US National Institutes of Health, US Department of Veterans Affairs, Janssen Research & Development, and IQVIA. This work was also supported by the Bio Industrial Strategic Technology Development Program (20001234) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea) and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992), and the Health Department from the Generalitat de Catalunya with a grant for research projects on SARS-CoV-2 and COVID-19 disease organized by the Direccio General de Recerca Innovacio en Salut. APU is supported by MRC-DTP [MR/K501256/1, MR/N013468/1] and Fundacion Alfonso Martin Escudero (FAME). GH is supported by the US National Library of Medicine (LM006910). The funders did not have any role in the study design, collection, analysis, and interpretation of data, writing of the report, and the decision to submit the article for publication. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Clinician Scientist Award programme, NIHR, Department of Veterans Affairs or the United States Government, NHS or the Department of Health, England. The authors have full access to the results generated and have the ability to work directly with data partners to investigate any discrepancies. Due to privacy laws, data are not moved outside of a site but the use of a common analytics framework and common data model enable the rapid sharing of results.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data partners received Institutional Review Board (IRB) approval or exemption. The use of VA data was reviewed by the Department of Veterans Affairs Central Institutional Review Board (IRB) and was determined to meet the criteria for exemption under Exemption Category 4(3) and approved the request for Waiver of HIPAA Authorization. The research was approved by the Columbia University Institutional Review Board as an OHDSI network study. The IRB number for use of HIRA data was AJIB-MED-EXP-20-065. SIDIAP analysis was approved by the Clinical Research Ethics Committee of the IDIAPJGol (project code: 20/070-PCV). Other databases used (IQVIA Open Claims and Optum EHR) are commercially available, syndicated data assets that are licensed by contributing authors for observational research. Licensees of these data have signed Data Use Agreements with the data vendors which detail the usage protocols for running retrospective research on these databases. All analyses performed in this study were in accordance with Data Use Agreement terms as specified by the data owners.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Analyses were performed locally in compliance with all applicable data privacy laws. Although the underlying data is not readily available to be shared, authors contributing to this paper have direct access to the data sources used in this study. All results (aggregate statistics, not presented at a patient-level with redactions for minimum cell count) are available for public inquiry. These results are inclusive of site-identifiers by contributing data sources to enable interrogation of each contributing site. All analytic code and result sets are made available at: https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis

https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
Eng Hooi Tan, Anthony G. Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L. Duvall, Kristine E. Lynch, Michael E. Matheny, Talita Duarte-Salles, Sergio Fernandez Bertolin, George Hripcsak, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M Alshammari, Heba Alghoul, Osaid Alser, Jennifer C.E. Lane, Dalia M Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Relcade, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana YH Lai, Fredrik Nyberg, Daniel R Morales, Jose D. Posada, Nigam H. Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan P Minty, Marc Suchard, Peter Rijnbeek, Patrick B Ryan, Daniel Prieto-Alhambra
medRxiv 2020.11.24.20236802; doi: https://doi.org/10.1101/2020.11.24.20236802
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
Eng Hooi Tan, Anthony G. Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L. Duvall, Kristine E. Lynch, Michael E. Matheny, Talita Duarte-Salles, Sergio Fernandez Bertolin, George Hripcsak, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M Alshammari, Heba Alghoul, Osaid Alser, Jennifer C.E. Lane, Dalia M Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Relcade, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana YH Lai, Fredrik Nyberg, Daniel R Morales, Jose D. Posada, Nigam H. Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan P Minty, Marc Suchard, Peter Rijnbeek, Patrick B Ryan, Daniel Prieto-Alhambra
medRxiv 2020.11.24.20236802; doi: https://doi.org/10.1101/2020.11.24.20236802

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)